Lütfiye Nilsun Altunal

5PUBLICATIONS
75CO-AUTHORS
Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 20, 2025
Impact of the COVID-19 Pandemic on CLABSI Rates and Antibiotic Resistance: A Multicenter Study in Türkiye.

Elif Sargın-Altunok, Şiran Keske, Ayşe Batırel

|Apr 18, 2024
Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial.

Lütfiye Nilsun Altunal, Mehtap Aydın, Ayşe Serra Özel

|Feb 22, 2023
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.

Lutfiye Nilsun Altunal, Dilek Yagcı Caglayık, Ayse Serra Ozel

|Oct 31, 2022
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.

Ahmet Omma, Ayse Batirel, Mehtap Aydin

|Sep 13, 2021
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.

Ali Mert, Haluk Vahaboğlu, Ferhat Arslan

Pageof 1

Frequent Collaborators

4 joint publications

Mehtap Aydın

3 joint publications

Ayşe Batırel

2 joint publications

Buket Ertürk Sengel

2 joint publications

Volkan Korten